ConductScience.org, home

Trial · NCT05361668

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTED40 mg Paltusotine18
Overall StudySTARTED80 mg Paltusotine18
Overall StudyAdverse Event40 mg Paltusotine1
Overall StudyAdverse Event80 mg Paltusotine1
Overall StudyPhysician Decision40 mg Paltusotine0
Overall StudyPhysician Decision80 mg Paltusotine3
Overall StudyWithdrawal by Subject40 mg Paltusotine0
Overall StudyWithdrawal by Subject80 mg Paltusotine1
Overall StudyCOMPLETED40 mg Paltusotine17
Overall StudyCOMPLETED80 mg Paltusotine13
Overall StudyNOT COMPLETED40 mg Paltusotine1
Overall StudyNOT COMPLETED80 mg Paltusotine5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05361668/flow